Re: Overspending driven by oversized single dose vials of cancer drugs
I suspect the cost savings proposed here are grossly overstated due to the simple fact that the cost to manufacture the drugs is essentially unrelated to the cost of the drug. The drug companies are selling their intellectual property and pricing the drugs to provide a certain number of treatments based on what the market will bear. This is a cute paper, but the prices for the treatments would simply rise in the years it would take to establish systems to reduce waste. Waste should be reduced when possible but this article is hyperbole.
Competing interests: No competing interests